Please login to the form below

Not currently logged in
Email:
Password:

cholera

This page shows the latest cholera news and features for those working in and with pharma, biotech and healthcare.

The power of pharma businesses to drive social change

The power of pharma businesses to drive social change

Our research teams are collaborating with peers from organisations around the world to help in the development of effective treatments for diseases such as Chagas, cholera, dengue fever and schistosomiasis.

Latest news

  • FDA approves first cholera vaccine in US FDA approves first cholera vaccine in US

    The approval also comes against the backdrop of a worldwide shortage in oral cholera vaccines, which include Valneva's Dukoral and the International Vaccine Institute's Shanchol. ... It is a live attenuated vaccine, incorporating a weakened strain of the

  • Sanofi enters vaccines partnership with Sutro Sanofi enters vaccines partnership with Sutro

    Sanofi Pasteur's vaccines currently cover 20 infectious diseases, including tuberculosis, cholera, influenza and hepatitis, and it is currently investigating a product to protect against the dengue virus.

  • J&J to buy remaining shares in Crucell

    as hepatitis, influenza, typhoid and cholera.

  • Kicking the habit

    Preliminary data from a phase I trial of the vaccine, which comprises a nicotine derivative conjugated to a recombinant cholera toxin B, indicated that self-reported quit rates were considerably greater

  • A Lucent View

    and cholera and GlaxoSmithKline is funding (still, since 1993) an international, co-ordinated research programme to fight TB.

More from news
Approximately 1 fully matching, plus 8 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Grace Communications

Grace Communications is an award winning, independent, full service, creative communications agency specialising in solving problems for healthcare brands....

Latest intelligence

The UK’s new five-year pricing agreement
Pharma has agreed to capped growth again - in exchange for uptake promises...
Digital applications are transforming the market access landscape
Organisations are leveraging new technology to implement a wider range of business models and, in essence, drive market access success by working smarter, faster and with greater economy....
Escaping the spin cycle of sub-optimal launch
...

Infographics